Osteoblast cellular cholesterol homeostasis
Osteoblast cellular cholesterol homeostasis. (A) Exogenous LDL uptake in osteoblast via LDL-LDLR endocytosis is an important source of CE and TG for lysosomal hydrolysis. Lysosomal acid lipase (LAL)-mediated lipid catabolism leads to the release of free cholesterol and free fatty acids (FFA) for further cellular needs. (B) Cholesterol formation begins with acetyl-coenzyme A (CoA), two molecules of which are converted into acetoacetyl-CoA by acetyl-CoA acetyltransferase (ACAT). The first step in the mevalonate pathway from 3-hydroxy-3-methylglutaryl (HMG)-CoA to mevalonate is catalyzed by HMG-CoA reductase (HMGCR), which is the main target of statins. This figure was created using Biorender.com (accessed on 13 March 2023).
Publication
Influence of Cholesterol on the Regulation of Osteoblast Function (2023) Alena Akhmetshina, et al. Metabolites. 2023 Apr;13(4). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | ATP | ATP | ncbigene_synonym | ATP8A2 | 51761 |
| Homo sapiens | Primates | ACAT | ACAT | ncbigene_synonym | ACAT1 | 38 |
| Homo sapiens | Primates | ACAT | ACAT | ncbigene_synonym | CES1 | 1066 |
| Homo sapiens | Primates | ACAT | ACAT | ncbigene_synonym | SOAT1 | 6646 |
| Homo sapiens | Primates | LDLR | LDLR | ncbigene_symbol | LDLR | 3949 |
| Homo sapiens | Primates | TG | TG | ncbigene_symbol | TG | 7038 |
| Homo sapiens | Primates | LAL | LAL | ncbigene_synonym | LIPA | 3988 |
| Homo sapiens | Primates | HMGCR | HMGCR | ncbigene_symbol | HMGCR | 3156 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| LDL | LDL | chebi:39026 | ||
| ATP | ATP | ATP | chebi:30616 | |
| Acetyl-CoA | acetyl-CoA | 3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate) | chebi:57288 | |
| Acetoacetyl-CoA | acetoacetyl-CoA | 3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-{[3-oxo-3-({2-[(3-oxobutanoyl)sulfanyl]ethyl}amino)propyl]amino}butyl] diphosphate} | chebi:57286 | |
| Citrate | citrate | chebi:133748 | ||
| Acetyl-CoA | acetyl-CoA | 3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate) | chebi:57288 | |
| Acetyl-CoA | acetyl-CoA | 3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate) | chebi:57288 | |
| CoA | CoA | 3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] diphosphate} | chebi:57287 | |
| FFA | FFA | 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid | chebi:42638 | |
| Cholesterol | cholesterol | cholesterol | chebi:16113 | |
| ATP | ATP | ATP | chebi:30616 | |
| HMG-CoA | HMG-CoA | 3'-phosphoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(3S)-4-carboxy-3-hydroxy-3-methylbutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate} | chebi:15467 | |
| Cholesterol | cholesterol | cholesterol | chebi:16113 | |
| Statins | statins | chebi:87631 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|